Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

Cited by (1,006)

Items 101–200 of 1,006

1. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
   Shahin Rafii, David C. Lyden, Robert Benezra, Koichi Hattori, Beate Heissig · 2002 · Nature reviews. Cancer
2. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.
   Chang Geol Lee, M. Heijn, Emmanuelle di Tomaso, Geneviève Griffon, Marek Ancukiewicz, Chieko Koike, K. R. Park, Napoleone Ferrara, R K Jain, Herman D. Suit et al. · 2000 · PubMed
3. Extending Survival with Chemotherapy in Metastatic Breast Cancer
   Joyce O’Shaughnessy · 2005 · The Oncologist
4. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.
   Marie C. Prewett, J Huber, Yiwen Li, A Santiago, W O'Connor, Karen D. King, James C. Overholser, Andrea T. Hooper, Bronislaw Pytowski, L Witte et al. · 1999 · PubMed
5. Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression
   Gregg L. Semenza · 2000 · Critical Reviews in Biochemistry and Molecular Biology
6. Dynamic Contrast-Enhanced Magnetic Resonance Imaging As a Biomarker for the Pharmacological Response of PTK787/ZK 222584, an Inhibitor of the Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, in Patients With Advanced Colorectal Cancer and Liver Metastases: Results From Two Phase I Studies
   Bruno Morgan, Anne Thomas, Joachim Drevs, Jürgen Hennig, Martin Büchert, Asvina Jivan, Mark A. Horsfield, K. Mross, Howard A. Ball, Lucy Lee et al. · 2003 · Journal of Clinical Oncology
7. The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2
   Ny Sin, Lihao Meng, Margaret Q. W. Wang, James Wen, William G. Bornmann, Craig M. Crews · 1997 · Proceedings of the National Academy of Sciences
8. Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia—Associated Iris Neovascularization in a Nonhuman Primate
   Anthony P. Adamis · 1996 · Archives of Ophthalmology
9. A role for VEGF as a negative regulator of pericyte function and vessel maturation
   Joshua I. Greenberg, David J. Shields, Samuel G. Barillas, Lisette M. Acevedo, Eric A. Murphy, Jianhua Huang, Lea Scheppke, Christian Stockmann, Randall S. Johnson, Niren Angle et al. · 2008 · Nature
10. Pharmacology and Pharmacodynamics of Bevacizumab as Monotherapy or in Combination with Cytotoxic Therapy in Preclinical Studies
    Hans‐Peter Gerber, Napoleone Ferrara · 2005 · Cancer Research
11. VEGF and Notch in Tip and Stalk Cell Selection
    Rosa E. Blanco, Holger Gerhardt · 2012 · Cold Spring Harbor Perspectives in Medicine
12. Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2)
    Hendrik Gille, Joe Kowalski, Bing Li, Jennifer E. LeCouter, Barbara Moffat, Thomas F. Zioncheck, Nicolas Pelletier, Napoleone Ferrara · 2001 · Journal of Biological Chemistry
13. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
    Lawrence F. Brown, Brygida Berse, Robert W Jackman, Kathi Tognazzi, Anthony J. Guidi, Harold F. Dvorak, Donald R. Senger, James L. Connolly, Stuart J. Schnitt · 1995 · Human Pathology
14. Retinopathy of prematurity
    Jing Chen, Lois E. H. Smith · 2007 · Angiogenesis
15. Combined inhibition of VEGF‐ and PDGF‐signaling enforces tumor vessel regression by interfering with pericyte‐mediated endothelial cell survival mechanisms
    Ralf Erber, Andreas Thurnher, Alice D. Katsen, Gesine Groth, H. Kerger, Hans‐Peter Hammes, Michael Dieter Menger, Axel Ullrich, Peter Vajkoczy · 2003 · The FASEB Journal
16. Immune Therapy for Cancer
    Michael Lawrence Dougan, Glenn Dranoff · 2008 · Annual Review of Immunology
17. The Carboxyl-terminal Domain(111–165) of Vascular Endothelial Growth Factor Is Critical for Its Mitogenic Potency
    Bruce A. Keyt, Lea T. Berleau, Hung Van Nguyen, Helen Chen, Henry G. Heinsohn, RICHARD L. VANDLEN, Napoleone Ferrara · 1996 · Journal of Biological Chemistry
18. Vascular endothelial growth factor (VEGF) signaling in tumor progression
    Robert Jr. Roskoski · 2007 · Critical Reviews in Oncology/Hematology
19. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis.
    Shweiki, D, Neeman, M, Itin, A, Keshet, E · 1995 · Proceedings of the National Academy of Sciences
20. Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells
    Eiji Ikeda, Marc G. Achen, Georg Breier, Werner Risau · 1995 · Journal of Biological Chemistry
21. Clinical Implications of Circulating Angiogenic Factors in Cancer Patients
    Ronnie T. P. Poon, Sheung-Tat Fan, John Wong · 2001 · Journal of Clinical Oncology
22. Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
    Schmittnaegel, Martina, Rigamonti, Nicolò, Kadioglu, Ece, Cassará, Antonino, Wyser Rmili, Céline, Kiialainen, Anna, Kienast, Yvonne, Mueller, Hans-Joachim, Ooi, Chia-Huey, Laoui, Damya et al. · 2017 · Science Translational Medicine
23. The role of tumor stroma in cancer progression and prognosis: Emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer
    Bremnes, Roy M., Dønnem, Tom, Al-Saad, Samer, Al-Shibli, Khalid, Andersen, Sigve, Sirera, Rafael, Camps, Carlos, Marinez, Inigo, Busund, Lill-Tove · 2011 · Journal of Thoracic Oncology
24. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma
    Berno Dankbar, Teresa Padró, Regine Leo, Birgit Feldmann, Martin H. Kropff, Rolf Michael Mesters, Hubert L. Serve, Wolfgang E. Berdel, Joachim Kienast · 2000 · Blood
25. Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective
    Marcin Kowanetz, Napoleone Ferrara · 2006 · Clinical Cancer Research
26. Hypoxic Regulation of Vascular Endothelial Growth Factor in Retinal Cells
    Lloyd Paul Aiello · 1995 · Archives of Ophthalmology
27. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.
    Lawrence F. Brown, Brygida Berse, R W Jackman, Kathi Tognazzi, E J Manseau, Harold F. Dvorak, Donald R. Senger · 1993 · PubMed Central
28. Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent
    Kenneth A. Thomas · 1996 · Journal of Biological Chemistry
29. Identification of an angiogenic mitogen selective for endocrine gland endothelium
    Jennifer E. LeCouter, Joe Kowalski, Jessica Foster, Phil Hass, Zemin Zhang, Lisa Dillard‐Telm, Gretchen D. Frantz, Linda K. Rangell, Leo Deguzman, Gilbert-André Keller et al. · 2001 · Nature
30. Akt Mediates Cytoprotection of Endothelial Cells by Vascular Endothelial Growth Factor in an Anchorage-dependent Manner
    Yasushi Fujio, Kenneth Walsh · 1999 · Journal of Biological Chemistry
31. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Donald R. Senger, S R Ledbetter, Kevin P. Claffey, A Papadopoulos-Sergiou, C A Peruzzi, Michael J. Detmar · 1996 · Europe PMC (PubMed Central)
32. VEGFR-3 and Its Ligand VEGF-C Are Associated with Angiogenesis in Breast Cancer
    Reija Valtola, Petri Salvén, Päivi Heikkilä, Jussi Taipale, Heikki Joensuu, Marko Rehn, Taina A. Pihlajaniemi, Herbert A. Weich, Robert M. deWaal, Kari K. Alitalo · 1999 · American Journal Of Pathology
33. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects
    Edouard J. Battegay · 1995 · Journal of Molecular Medicine
34. Vascular Endothelial Growth Factor: Molecular and Biological Aspects
    Napoleone Ferrara · 1999 · Current topics in microbiology and immunology
35. From angiogenesis to neuropathology
    David A. Greenberg, Kunlin Jin · 2005 · Nature
36. Roles for Growth Factors in Cancer Progression
    Esther Witsch, Michael Sela, Yosef Yarden · 2010 · Physiology
37. Endothelial receptor tyrosine kinases involved in angiogenesis.
    Tuija Mustonen, Kari K. Alitalo · 1995 · The Journal of Cell Biology
38. Adipocyte and lipid metabolism in cancer drug resistance
    Yihai Cao · 2019 · Journal of Clinical Investigation
39. Angiogenesis promoted by vascular endothelial growth factor: Regulation through α 1 β 1 and α 2 β 1 integrins
    Donald R. Senger, Kevin P. Claffey, Julie E. Benes, Carole A. Perruzzi, A Papadopoulos-Sergiou, Michael J. Detmar · 1997 · Proceedings of the National Academy of Sciences
40. VEGF Receptor Signaling in Tumor Angiogenesis
    Gerald McMahon · 2000 · The Oncologist
41. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue.
    Roy A. Fava, Nancy J. Olsen, G Spencer-Green, K T Yeo, Tet-Kin Yeo, Brygida Berse, R W Jackman, Donald R. Senger, Harold F. Dvorak, Lawrence F. Brown · 1994 · The Journal of Experimental Medicine
42. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.
    William T. Bellamy, L Richter, Yvette M. Frutiger, Thomas M. Grogan · 1999 · PubMed
43. Pharmacologic resistance in colorectal cancer: a review
    William A. Hammond, Abhisek Swaika, Kabir Mody · 2015 · Therapeutic Advances in Medical Oncology
44. VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix
    Zoya Gluzman‐Poltorak, Tzafra Cohen, Revital Sivan, Yelena Kandelis, G. Spira, Israël Vlodavsky, Eli Keshet, Gera Neufeld · 1997 · Journal of Biological Chemistry
45. Intravitreous Injections of Vascular Endothelial Growth Factor Produce Retinal Ischemia and Microangiopathy in an Adult Primate
    Michael J. Tolentino, Joan W. Miller, Evangelos S. Gragoudas, Frederick A. Jakobiec, Evelyn A. Flynn, Klio Chatzstefanou, Napoleone Ferrara, Anthony P. Adamis · 1996 · Ophthalmology
46. Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer
    Suparna Bonthala Wedam, Jennifer A. Low, Sherry X. Yang, Catherine K. Chow, Peter L. Choyke, David N. Danforth, Stephen M. Hewitt, Arlene W. Berman, Seth M. Steinberg, David J. Liewehr et al. · 2006 · Journal of Clinical Oncology
47. How Tumors Become Angiogenic
    Noël Bouck, Veronica Stellmach, Stephanie C. Hsu · 1996 · Advances in cancer research
48. Anti-VEGF Antibody Treatment of Glioblastoma Prolongs Survival But Results in Increased Vascular Cooption
    James L. Rubenstein, Jin Kim, Tomoko Ozawa, Michael Zhang, Manfred Westphal, Dennis F. Deen, Marc A. Shuman · 2000 · Neoplasia
49. VEGFs, receptors and angiogenesis
    Tanja Veikkola, Kari K. Alitalo · 1999 · Seminars in Cancer Biology
50. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal
    Laura E. Benjamin, Eli Keshet · 1997 · Proceedings of the National Academy of Sciences
51. Structure and Function of VEGF/VEGF-receptor System Involved in Angiogenesis.
    Masabumi Shibuya · 2001 · Cell Structure and Function
52. Hypoxia and Vascular Endothelial Growth Factor Selectively Up-regulate Angiopoietin-2 in Bovine Microvascular Endothelial Cells
    Hideyasu Oh, Hitoshi Takagi, Kiyoshi Suzuma, Atsushi Otani, Miyo Matsumura, Yoshihito Honda · 1999 · Journal of Biological Chemistry
53. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids.
    Janet F. McLaren, A Prentice, David S. Jones, Stephanie A. Millican, Karin H. Müller, Andrew Sharkey, S. Kaye Smith · 1996 · Journal of Clinical Investigation
54. Biology and therapeutic targeting of vascular endothelial growth factor A
    Lorena Pérez, Napoleone Ferrara · 2023 · Nature Reviews Molecular Cell Biology
55. Prognostic Significance of Vascular Endothelial Growth Factor Protein in Node-Negative Breast Carcinoma
    Giulio Maria Gasparini, Emanuela Bonoldi, Carlo Gatti, Orazio Vinante, Masakazu Toi, T. Tominaga, Massimo Gion, Ruggero Dittadi, Paolo Verderio, Patrizia Boracchi et al. · 1997 · JNCI Journal of the National Cancer Institute
56. Molecular Mechanisms and Future Implications of VEGF/VEGFR in Cancer Therapy
    Sonia A. Patel, Monique B. Nilsson, Xiuning Le, Tina Cascone, Rakesh K. Jain, John Victor Heymach · 2022 · Clinical Cancer Research
57. A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer
    Melody Cobleigh · 2003 · Seminars in Oncology
58. Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population
    Daniel Jay Brat, Amilcar Antonio Castellano-Sanchez, STEPHEN B. HUNTER, Marcia Pecot, Cynthia Cohen, Elizabeth H. Hammond, Sarojini N. Devi, Balveen Kaur, Erwin G. Van Meir · 2004 · Cancer Research
59. Cell Type-Specific Expression of Angiopoietin-1 and Angiopoietin-2 Suggests a Role in Glioblastoma Angiogenesis
    Astrid Stratmann, Werner Risau, Karl Heinz Plate · 1998 · American Journal Of Pathology
60. Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor
    Christian Wiesmann, Germaine Fuh, Hans W. Christinger, Charles W. Eigenbrot, James A. Wells, Abraham M. de Vos · 1997 · Cell
61. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain
    Moosa Mohammadi, Scott Froum, James M. Hamby, Mel C. Schroeder, Robert L. Panek, Gina H. Lu, Anna V. Eliseenkova, David Green, Joseph Schlessinger, Stevan R. Hubbard · 1998 · The EMBO Journal
62. Vascular Endothelial Cell Growth Factor Promotes Tyrosine Phosphorylation of Mediators of Signal Transduction That Contain SH2 Domains
    Danqun Guo, Qing Jia, Ho-Yeong Song, Robert S. Warren, David B. Donner · 1995 · Journal of Biological Chemistry
63. VEGF and angiopoietin signaling in tumor angiogenesis and metastasis
    Pipsa Saharinen, Lauri Eklund, Kristina H. Pulkki, Petri Bono, Kari K. Alitalo · 2011 · Trends in Molecular Medicine
64. Angiogenesis Inhibitors: Current Strategies and Future Prospects
    Kristina M. Cook, William Douglas Figg · 2010 · CA A Cancer Journal for Clinicians
65. Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible In vivo regulatory mechanisms
    Karl Heinz Plate, Georg Breier, Herbert A. Weich, Hans Dieter Mennel, Werner Risau · 1994 · International Journal of Cancer
66. Emerging new therapeutic antibody derivatives for cancer treatment
    Shijie Jin, Yanping Sun, Liang Xiao, Xinyu Gu, Jiangtao Ning, Yingchun Xu, Shuqing Chen, Liqiang Pan · 2022 · Signal Transduction and Targeted Therapy
67. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function.
    Dmitry I. Gabrilovich, Tatsuhiro Ishida, Sorena Nadaf, Joyce Ellen Ohm, D P Carbone · 1999 · PubMed
68. VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor binding
    S. Soker, Hua Miao, M. Nomi, S. Takashima, M. Klagsbrun · 2002 · Journal of Cellular Biochemistry
69. Induction of Vascular Endothelial Growth Factor by Tumor Necrosis Factor α in Human Glioma Cells
    Masahiro Ryuto, Mayumi Ono, Hiroto Izumi, Shigeo Yoshida, Herbert A. Weich, Kimitoshi Kohno, Michihiko Kuwano · 1996 · Journal of Biological Chemistry
70. Vascular endothelial growth factor: Crystal structure and functional mapping of the kinase domain receptor binding site
    Yves A. Muller, Bing Li, Hans W. Christinger, James A. Wells, Brian C. Cunningham, Abraham M. de Vos · 1997 · Proceedings of the National Academy of Sciences
71. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics
    Priti S. Hegde, Jeffrey J. Wallin, Christoph Mancao · 2017 · Seminars in Cancer Biology
72. The Role of Vascular Endothelial Growth Factor in Angiogenesis
    Napoleone Ferrara, Hans‐Peter Gerber · 2001 · Acta Haematologica
73. Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy
    Gang Niu, Xiaoyuan Shawn Chen · 2010 · Current Drug Targets
74. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1 1Edited by I. A. Wilson
    Yvonne Chen, Christian Wiesmann, Germaine Fuh, Bing Li, Hans W. Christinger, Patrick McKay, Abraham M. de Vos, Henry B. Lowman · 1999 · Journal of Molecular Biology
75. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
    Corey K. Goldman, Richard L. Kendall, Gustavo Cabrera, Liliana Soroceanu, Yuji Heike, G. Yancey Gillespie, Gene P. Siegal, Xianzhi Mao, Andrew J. Bett, William R. Huckle et al. · 1998 · Proceedings of the National Academy of Sciences
76. Vascular Growth Factors and Lymphangiogenesis
    Lotta Jussila, Kari K. Alitalo · 2002 · Physiological Reviews
77. Oncogene addiction: setting the stage for molecularly targeted cancer therapy
    Sreenath V. Sharma, Jeffrey E. Settleman · 2007 · Genes & Development
78. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA–PCL–PDMAEMA triblock copolymers
    Caihong Zhu, Sooyeon Jung, Sibin Luo, Fenghua Meng, Xiulin Zhu, Tae Gwan Park, Zhiyuan Zhong · 2009 · Biomaterials
79. The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR Agents
    Josep M. Tabernero · 2007 · Molecular Cancer Research
80. Vasculogenesis and Angiogenesis
    Sybill Patan · 2004 · Cancer treatment and research
81. Selective Inhibition of Vascular Endothelial Growth Factor–Mediated Angiogenesis by Cyclosporin a
    Gabriela Hernández, Olga V. Volpert, Miguel Angel Iñiguez, Elisa Lorenzo, Sara Martı́nez-Martı́nez, Raquel Grau, Manuel Fresno, Juan Miguel Redondo · 2001 · The Journal of Experimental Medicine
82. Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro
    Yaning Wang, David Fei, Martin Vanderlaan, An Song · 2004 · Angiogenesis
83. Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
    M Kuroki, Emile E. Voest, Shiro Amano, Laurens Victor Beerepoot, Seiji Takashima, Michael J. Tolentino, Robert Y. Kim, Richard M. Rohan, Kathryn A. Colby, K T Yeo et al. · 1996 · Journal of Clinical Investigation
84. Heterogeneity of the Tumor Vasculature
    Janice A. Nagy, Sung-Hee Chang, Shou‐Ching Shih, Ann M. Dvořàk, Harold F. Dvorak · 2010 · Seminars in Thrombosis and Hemostasis
85. Halting angiogenesis suppresses carcinoma cell invasion
    Mihaela Skobe, Patricia Rockwell, Neil I. Goldstein, Silvia Vosseler, Norbert E. Fusenig · 1997 · Nature Medicine
86. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo.
    Birgit Millauer, M P Longhi, Karl Heinz Plate, L K Shawver, Werner Risau, Axel Ullrich, Laurie M. Strawn · 1996 · PubMed
87. Anti-angiogenic therapy: current challenges and future perspectives
    Lopes-Coelho, Filipa, Martins, Filipa, Pereira, Sofia A., Serpa, Jacinta · 2021 · International Journal of Molecular Sciences
88. Sunitinib: A VEGF and PDGF receptor protein kinase and angiogenesis inhibitor
    Robert Jr. Roskoski · 2007 · Biochemical and Biophysical Research Communications
89. Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration
    Klaus Podar, Yu‐Tzu Tai, Faith E. Davies, Suzanne Lentzsch, Martin Sattler, Teru Hideshima, Boris Kin Lin, Deepak Kumar Gupta, Yoshihito Shima, Dharminder Chauhan et al. · 2001 · Blood
90. PRECLINICAL AND PHASE 1A CLINICAL EVALUATION OF AN ANTI-VEGF PEGYLATED APTAMER (EYE001) FOR THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION
    THE EYETECH STUDY GROUP · 2002 · Retina
91. Untitled work
    1996 · PubMed
92. The role of vascular endothelial growth factor in pathological angiogenesis
    Napoleone Ferrara · 1995 · Breast Cancer Research and Treatment
93. A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation1
    Dawn E. Clark, S. Kaye Smith, Yulong He, Kate A. Day, Diana R. Licence, Anthony N. Corps, Rosemarie Lammoglia, David S. Jones · 1998 · Biology of Reproduction
94. Large Intervening Non-Coding RNA HOTAIR is Associated with Hepatocellular Carcinoma Progression
    YJ Geng, SL Xie, Q Li, Jian Ma, G-Y Wang · 2011 · Journal of International Medical Research
95. Key factors in the acquisition of contrast kinetic data for oncology
    Jeffrey L. Evelhoch · 1999 · Journal of Magnetic Resonance Imaging
96. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice.
    Douglas A. Arenberg, Steven L. Kunkel, Peter J. Polverini, Mary Glass, Marie D. Burdick, Robert M. Strieter · 1996 · Journal of Clinical Investigation
97. Curcumin Is an In Vivo Inhibitor of Angiogenesis
    Jack L. Arbiser, Nancy Klauber, Richard M. Rohan, Robert van Leeuwen, Mou‐Tuan Huang, Carolyn Fisher, Evelyn A. Flynn, Hugh Randolph Byers · 1998 · Molecular Medicine
98. Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2.
    Philip Kunkel, Ulrike Ulbricht, Peter Böhlen, Marc Alexander Brockmann, Regina Fillbrandt, Dimitrios Stavrou, Manfred Westphal, Katrin Lamszus · 2001 · PubMed
99. The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes.
    Hideyasu Oh, Hitoshi Takagi, C Takagi, Kiyoshi Suzuma, A. Otani, Kazuhiro Ishida, Miyo Matsumura, Yuichiro Ogura, Y Honda · 1999 · PubMed
100. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.
     Michael R. Freeman, Francis X. Schneck, Michael L. Gagnon, Christopher L. Corless, Shay Söker, Kathy Niknejad, George Earl Peoples, Michael Klagsbrun · 1995 · PubMed